Samiksha Jaiswal (Editor)

Mebeverine

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Routes of administration
  
By mouth

CAS Number
  
2753-45-9

ATC code
  
A03AA04 (WHO)

Molar mass
  
429.6 g/mol

Mebeverine

Trade names
  
Colofac, Duspamen and others

AHFS/Drugs.com
  
International Drug Names

Legal status
  
UK: P (Pharmacy medicines) US: Not FDA approved In general: ℞ (Prescription only)

Mebeverine is a drug whose major therapeutic role is in the treatment of irritable bowel syndrome (IBS) and the associated abdominal cramping. It works by relaxing the muscles in and around the gut. It is a musculotropic antispasmodic drug without anticholinergic side effects. The drug is also indicated for treatment of gastrointestinal spasm secondary to organic disorder.

Contents

Indications

Spastic functional disturbances of the colon:

  • Irritable bowel syndrome in its primary form
  • Irritable bowel syndrome associated with organic lesions of the gastrointestinal tract, such as diverticulosis and diverticulitis, regional enteritis, disease of the gallbladder and gall ducts, gastric and duodenal ulcers, dysentery, and aspecific or specific inflammation of the digestive tract
  • Mebeverine should be taken 20 minutes before meals.

    Mechanism of action

    Mebeverine is an antimuscarinic. It is also an inhibitor of calcium-depot replenishment. Musculotropic compounds act directly on the gut muscles at the cellular level to relax them. This relieves painful muscle spasms of the gut, without affecting its normal motility. Mebeverine is used to relieve symptoms of irritable bowel syndrome and related intestinal disorders that are the result of spasms in the intestinal muscles. These include colicky abdominal pain and cramps, diarrhoea alternating with constipation and flatulence (wind).

    Adverse effects

    Side effects may include:

  • Indigestion or heartburn
  • Constipation
  • Dizziness
  • Insomnia (difficulty sleeping)
  • Loss of appetite
  • Headache
  • Tiredness
  • Slow heartbeat
  • Rash and/or itchy skin
  • Nausea
  • Acne
  • Since 1978, 21 cases of severe adverse reactions to mebeverine were reported in the Netherlands. Most reactions consisted of urticaria or maculopapular rash, sometimes accompanied by fever, polyarthritis, thrombocytopenia or angioedema.

    Very rarely, people taking this medicine may develop allergic reactions.

    Pregnancy and breastfeeding

    Mebeverine passes into breast milk, but the amount is considered too small to be harmful to a nursing infant.

    Driving and using machines

    Mebeverine is unlikely to affect the ability to operate machinery or to drive, yet not completely out of the question.

    History

    It was first registered in 1965.

    Availability

    Mebeverine is a generic drug and is available internationally under many brand names.

    References

    Mebeverine Wikipedia